About this trial
This research will use biobehavioral approaches to generate understanding about the linkages between sleep duration and timing, stressful life events, and depressive symptoms in adolescents, with a long-term aim of developing effective preventative interventions.
Eligibility criteria
Qualifiers
14-18 years of age
Currently in high school
short and late sleep (weekday sleep duration ≤ 7 h and bedtime ≥ 22:30 (10:30 pm); n=100) or long and early sleep (weekday sleep duration > 7 hours and bedtime ≤ 22:30 (10:30 pm); n=50), indexed by the Munich Chronotype Questionnaire
Lifetime stressful event frequency ≥ 2 on the Stress and Adversity Inventory (STRAIN) Screener
Disqualifiers
Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for current moderate to severe alcohol/substance use disorder (≥4 symptoms);
Current clinician-provided diagnosis of narcolepsy or idiopathic hypersomnia;
Lifetime diagnosis of bipolar or schizophrenia spectrum disorder;
Certain medical conditions (e.g., serious neurological disorder, heart failure or serious heart trouble, history of head injury with unconsciousness > 5 minutes);
Trial design
Treatments tested in this trial
- Sleep extension and advance
- Regular sleep duration and timing
Treatment groups
Sponsors and collaborators
University of Oregon
Lead sponsor
Oregon Research Institute
Collaborator
University of Pittsburgh
Collaborator
National Institute of Mental Health (NIMH)
Collaborator